Reports Library Publication
Insight Consumer Healthcare Europe August / September 2026
22nd September 2026 by CHC Insight
- Cough & Cold Lower incidence prompts marketer strategy shift
- Allergy Remedies Strong pollen season drives activity
- Healthy High Streets The value of improved healthcare access
- Longevity Focus evolves from lifespan to healthspan
- Innovation Round-up Beiersdorf debuts ProbioM8 range
Order this report
Why buy this report?
"Seasonal factors made for a challenging year in cough & cold, pushing some marketers to reposition brands around broader lifestyle needs. Established brands including Strepsils (Reckitt), Mucosolvan (Opella) and Vicks (P&G) also moved into adjacent categories, underlining how category boundaries are blurring. Allergy remedies followed the opposite path, with a stronger, longer pollen season – said to be linked to climate change – driving double-digit retail growth in several markets. This issue also explores the potential benefits of expanding healthcare services on UK high streets and how CHC players are promoting longevity and “healthspan”."
Nicholas Hall